Showing results (871-880 of 932) with videos related to
Sort By:
Pageof 94
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.Virchows Archiv : an International Journal of Pathology|February 6, 2026
Evaluation of homologous recombination testing in ovarian carcinomaVera M Witjes, Joanne A de Hullu, Angela van Remortele, et al.The Lancet. Oncology|November 25, 2010
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activityWyndham H Wilson, Owen A O'Connor, Myron S Czuczman, et al.Molecular Cancer Therapeutics|September 15, 2011
The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivoJun Chen, Sha Jin, Vivek Abraham, et al.Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2024
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO studyA van Ommen-Nijhof, T G Steenbruggen, T G Wiersma, et al.Molecular Cancer Research : MCR|October 17, 2008
Potentiation of temozolomide cytotoxicity by poly(ADP)ribose polymerase inhibitor ABT-888 requires a conversion of single-stranded DNA damages to double-stranded DNA breaksXuesong Liu, Yan Shi, Ran Guan, et al.Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinaseSheela A Thomas, Tongmei Li, Keith W Woods, et al.Journal of Medicinal Chemistry|January 20, 2006
Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesisAndrew M Petros, Jurgen Dinges, David J Augeri, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2014
Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequencesGerald T Keusch, Donna M Denno, Robert E Black, et al.Pageof 94